Skip to main content
. 2015 Jan 11;75(3):579–586. doi: 10.1007/s00280-014-2671-x

Table 5.

Pharmacokinetic parameters of SN-38 and pharmacogenetic data of patients received 180 mg/m2 of PEP02

Patient unique number AUC0–∞
(hr-ng/mL)
C max
(ng /mL)
t 1/2
(hr)
UGT1A1*6 UGT1A1*28
201 906 13.3 41.4 W/W W/W
202 549 10.4 28.2 W/W W/W
203 3,084 23.3 59.0 V/W V/W
103 1,159 10.2 104 ND ND

V variant; W wild type

ND not done